Monica Ligueros‐Saylan

Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials

Philippe Gevaert, Theodore A. Omachi, Jonathan Corren et al. · Journal of Allergy and Clinical Immunology · 2020 · 697 citations · Full text

Medicine, Otolaryngology, Pharmacotherapy +17

Pharmacokinetics and Pharmacodynamics of LCZ696, a Novel Dual‐Acting Angiotensin Receptor—Neprilysin Inhibitor (ARNi)

Jessie Gu, Adele Noè, Priya Chandra et al. · The Journal of Clinical Pharmacology · 2009 · 502 citations

Medicine, Pharmacokinetics, Pharmacology +17

Vildagliptin, a Dipeptidyl Peptidase-IV Inhibitor, Improves Model-Assessed β-Cell Function in Patients with Type 2 Diabetes

Andrea Mari, William M. Sallas, Yanling He et al. · The Journal of Clinical Endocrinology & Metabolism · 2005 · 362 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Omalizumab for the Treatment of Multiple Food Allergies

Robert A. Wood, Alkis Togias, Scott H. Sicherer et al. · New England Journal of Medicine · 2024 · 309 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Hyperglycemia Associated With Pasireotide: Results From a Mechanistic Study in Healthy Volunteers

Robert R. Henry, Theodore P. Ciaraldi, Debra Armstrong et al. · The Journal of Clinical Endocrinology & Metabolism · 2013 · 250 citations · Full text

Medicine, Endocrinology, Pharmacology +17